Name: 재생 의학 시장을 위한 콜라겐 및 젤라틴 - Prime research
SKU: PH856
Availability: InStock

보고서 요약(국문)

재생 의학용 콜라겐 및 젤라틴 글로벌 시장 개요
재생 의학용 콜라겐 및 젤라틴 글로벌 시장은 2021년 6억 529만 달러 규모였으며, 2029년에는 11억 8,437만 달러에 이를 것으로 예상됩니다. 예측 기간(2023~2030년) 동안 연평균 성장률(CAGR)은 10.67%입니다.
젤라틴과 콜라겐은 주로 피부와 뼈에 존재하는 단백질이지만 인체 전체에 분포합니다. 특정 나이가 되면 체내 콜라겐 생성량이 감소합니다. 콜라겐 부족은 골다공증, 만성 상처, 심혈관 질환, 뼈 및 관절 통증, 신경퇴행성 질환과 같은 만성 질환을 악화시키고 유발합니다.

출처: DataM Intelligence 분석(2021)
재생의학용 콜라겐 및 젤라틴 글로벌 시장 동향
골다공증 및 골관절염 등 만성 질환의 발병률 증가로 인해 재생의학용 콜라겐 및 젤라틴에 대한 수요가 증가하고 있습니다. 연구 개발 투자 증가와 신제품 출시 확대가 시장 성장을 견인할 것으로 예상됩니다.
신제품 출시 증가와 연구 개발 및 임상 연구 확대는 시장 성장을 촉진할 것입니다.
재생의학용 콜라겐 및 젤라틴 글로벌 시장은 주로 골다공증 및 골관절염과 같은 질환의 증가로 인한 의료 산업의 혁신적인 제품 수요에 의해 주도됩니다. 만성 질환은 장기 및 조직 손실을 초래할 수 있으며, 이는 재생의학용 콜라겐 및 젤라틴 기반 생체 재료 개발을 촉진합니다. 지난 수십 년 동안 생분해성, 생체 적합성, 낮은 면역원성, 손쉬운 확보, 그리고 높은 활용도라는 상당한 이점 덕분에 재생 의학 분야에서 콜라겐 및 젤라틴의 활용도가 크게 증가했으며, 이는 재생 의학용 콜라겐 및 젤라틴 시장의 성장을 촉진하고 있습니다. 콜라겐 및 젤라틴의 재생 특성에 대한 연구 개발 건수가 증가함에 따라 시장 성장이 더욱 가속화되고 있습니다.
다양한 자금 지원, 혁신적인 기술 발전, 그리고 최신 혁신 제품 출시가 증가하면서 재생 의학용 콜라겐 및 젤라틴에 대한 수요가 높아지고 있습니다. 예를 들어, 의료 기술 기업인 Integra LifeSciences Corporation은 2022년 3월에 NeuraGen 3D Nerve Guide Matrix를 출시했습니다. 이는 말초 신경의 단절 부위를 복구하여 최적의 환경을 제공함으로써 완전한 기능 회복을 가능하게 하는 흡수성 신경 복구 임플란트입니다.
하지만 콜라겐 및 젤라틴을 이용한 재생 의학의 높은 비용은 시장 성장을 저해하는 요인으로 작용할 수 있습니다.

하지만 콜라겐 및 젤라틴 재생 의학 시장의 높은 성장률은 성장을 저해하는 주요 요인입니다. 시장에 대체 생체 재료가 등장함에 따라 콜라겐 및 젤라틴 시장 성장이 저해될 수 있습니다.
COVID-19 영향 분석
코로나19 팬데믹은 전 세계 재정 전망, 운영 및 위기 대응 전략에 부정적인 영향을 미쳤습니다. 특히 의료 산업은 심각한 타격을 입었으며, 콜라겐 및 젤라틴 재생 의학 시장 또한 코로나19로 인해 막대한 손실을 경험했습니다. 그러나 현재 시장 참여자들은 연구 개발에 힘쓰고 팬데믹에 대응하기 위한 최첨단 제품을 개발하는 등 장단기 성장 전략을 수정하고 있습니다. 전 세계적으로 다양한 이니셔티브, 협력 및 인수합병이 활발히 진행되면서 시장 성장을 촉진하고 있습니다. 예를 들어, 2021년 10월 Symstese와 L'Oreal은 생체 재료 분야에서 장기 연구 개발 계약을 체결하여 인체 조직 재생을 위한 생체 재료 개발에 대한 새로운 과학적 관점을 연구하기로 했습니다.

재생 의학용 콜라겐 및 젤라틴 글로벌 시장 - 부문 분석
정형외과 부문은 예측 기간(2023-2030년) 동안 가장 빠른 연평균 성장률(CAGR)을 기록할 것으로 예상됩니다.
정형외과 부문은 전 세계 재생 의학용 콜라겐 및 젤라틴 시장에서 가장 큰 시장 점유율을 차지하고 있습니다. 정형외과에서는 개방 골절, 관절 성형술, 절단 또는 척추 수술 후 예방적 차원에서 콜라겐 플리스가 사용됩니다. 국제 폐경 학회(International Menopause Society)의 저널인 Climatric의 2021년 보고서에 따르면, 골다공증은 매년 890만 건 이상의 골절을 유발하는 주요 원인입니다. 전 세계적으로 약 2억 명의 여성이 골다공증을 앓고 있는 것으로 추정됩니다.
뼈 관련 질환을 앓는 사람들의 증가와 기술 발전 및 연구/임상 시험의 증가는 시장 성장을 견인하고 있습니다. 예를 들어, 2021년 9월 PB Leiner는 SOLUGEL 콜라겐 펩타이드를 섭취한 중년의 활동적인 사람들을 대상으로 관절 통증을 조사한 임상 연구 결과를 발표했습니다. 이 연구는 참가자들이 겪는 불편함과 통증이 크게 감소했음을 보여주었습니다. 이 연구는 플로리다 주립대학교에서 수행되었으며 PB Leiner의 승인을 받았습니다.

출처: DataM Intelligence 분석(2021)
글로벌 재생 의학용 콜라겐 및 젤라틴 시장 – 지역별 분석
북미는 글로벌 재생 의학용 콜라겐 및 젤라틴 시장에서 가장 큰 시장 점유율을 차지하고 있습니다.
북미가 글로벌 재생 의학용 콜라겐 및 젤라틴 시장을 주도하는 주요 이유는 골다공증, 골관절염 등 뼈 또는 관절 관련 질환의 유병률 증가, 잘 구축된 의료 인프라, 그리고 연구 개발 활동에 대한 높은 투자입니다. 또한, 광범위한 환자 기반도 북미의 시장 점유율 성장에 기여하고 있습니다. 골관절염 행동 연합(Osteoarthritis Action Alliance)에 따르면, 2021년 미국에서는 3,250만 명 이상이 골관절염을 앓고 있으며, 이는 전 세계 인구의 약 25%에 해당합니다.
또한, 제품 출시 증가가 시장 성장의 주요 요인입니다. GDP 대비 의료비 지출 증가와 같은 다른 요인들도 시장 성장을 촉진하고 있습니다. 이 지역에서는 많은 주요 개발, 기술 발전, 협력 및 계약이 활발히 진행되고 있습니다. 예를 들어, 2021년 1월 Integra Lifesciences Corporation은 돼지 방광 기질 플랫폼 기반의 제품과 기술을 보유한 혁신적인 재생 의학 기업인 ACell Inc. 인수를 완료했다고 발표했습니다.

출처: DataM Intelligence 분석(2021)
글로벌 재생 의학용 콜라겐 및 젤라틴 시장 - 경쟁 환경
재생 의학용 콜라겐 및 젤라틴 시장은 국내외 기업들의 존재로 인해 경쟁이 매우 치열합니다. Integra Lifesciences Holdings Corporation, Nitta Gelatin, GELITA AG, Collagen Matrix Inc., Blafar Ltd., PB Leiner, Royal DSM, Symatese, Olaregen Therapeutics, Collagen Solutions Plc 등 주요 기업들이 시장 성장에 기여하고 있습니다. 이들 기업들은 신제품 출시, 인수합병, 파트너십, 협력 등 다양한 성장 전략을 추진하고 있습니다. 예를 들어, 2021년 5월 Generex Biotechnology의 자회사인 Olaregan Therapeutics는 Nexgen Medical Sdn Bhd Inc.와 유통 계약을 체결했습니다. Nexgen은 말레이시아에서 상처 치료 제품인 Excellagen을 수입 및 판매할 예정입니다.

Integra Lifesciences Holdings Corporation:
개요:
Integra LifeSciences Corp는 Bactiseal, CerebroFlo, DuraSeal, Integra, MicroMatrix 등을 포함한 고품질 신경외과 및 재생 조직 기술 제품을 제공하는 의료 기술 회사입니다.

제품 포트폴리오:
SurgiMend: 신생아 및 태아 소의 피부에서 추출한 새로운 무세포 콜라겐 매트릭스입니다. 다른 생물학적 또는 합성 제품에 비해 연조직 재건 및 복구에 여러 이점을 제공합니다.
주요 개발: 2021년 7월, 의료 기술 기업인 Integra LifeSciences Corporation은 의료 성능 개선 기업인 Vizient Inc.로부터 연조직 재건 제품인 SurgiMend에 대한 혁신 기술 계약을 체결했다고 발표했습니다.

글로벌 재생 의학용 콜라겐 및 젤라틴 시장 보고서는 약 40개 이상의 시장 데이터 표, 45개 이상의 그림, 그리고 약 200페이지 분량으로 구성되어 있습니다.

보고서 요약(영어 원문)

Global Collagen & Gelatin for Regenerative Medicine Market- Overview
The global collagen & gelatin for regenerative medicine market was valued at US$ 605.29 million in 2021 and is estimated to reach US$ 1,184.37 million by 2029, growing at a CAGR of 10.67% during the forecast period (2023-2030).
Gelatin and collagen are proteins mainly found in the skin and bones but are present throughout the human body. After a specific age, the natural collagen generation in the body diminishes. The absence of collagen aggravates and promotes chronic ailments such as osteoporosis, chronic wounds, cardiovascular diseases, bone and joint discomfort, and neurodegenerative disorders.

Source: DataM Intelligence Analysis (2021)
Global Collagen & Gelatin for Regenerative Medicine-Market Dynamics
The increasing demand for these collagen & gelatin for regenerative medicines is due to the rising incidence of bone-related disorders. The rising number of research and development expenditures and growth in novel product launches are expected to drive market growth.
The increasing number of novel product launches and rising research and development or clinical studies will drive market growth.
The global market for collagen & gelatin for regenerative medicine is primarily driven by the healthcare industry's demand for these innovative products due to increasing illnesses, including osteoporosis and osteoarthritis. Chronic diseases can result in organ and tissue loss which drives the development of collagen and gelatin-based biomaterials for regenerative medicine. Its purpose in regenerative medicine has been growing substantially over the past few decades owing to the significant advantage of being biodegradable, biocompatible, low immunogenicity, readily available, and highly versatile, boosting the growth of the collagen and gelatin market for regenerative medicine. The rising number of research and development studies on collagen and gelatin’s regenerative properties are driving the market’s growth.
Various funding, novel technological advancements, and the number of the latest, innovative product launches are increasing, leading to the high demand for these collagen & gelatin for regenerative medicine. For instance, in Mar 2022, Integra LifeSciences Corporation, medical technology company, launched its NeuraGen 3D Nerve guide Matrix. It’s a nerve repair resorbable implant as it repairs discontinuities of the peripheral nerve that provides an optimized environment for may give high complete functional recovery.
The high costs associated with collagen & gelatin regenerative medicine will hamper the market’s growth.
However, high rates of collagen & gelatin regenerative medicine are the major factor restraining the growth. The availability of alternative biomaterials in the market may hinder the collagen & gelatin market growth.
COVID-19 Impact Analysis
The pandemic has negatively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The collagen & gelatin regenerative medicine market has experienced huge losses due to COVID. But now, the market participants are changing their long-term and short-term growth strategies by utilizing the research market and creating cutting-edge items to combat the pandemic. Various initiatives, collaborations and mergers are happening worldwide, boosting the market’s growth. For instance, in Oct 2021, Symstese and L’Oreal signed a long-term R&D agreement in the biomaterial field in which they will study novel scientific perspectives of biomaterial developed for human tissues for regeneration.
Global Collagen & Gelatin for Regenerative Medicine Market- Segment Analysis
The orthopedic segment is expected to grow at the fastest CAGR during the forecast period (2023-2030)
The Orthopedic segment is the highest market holder in the global collagen & gelatin for regenerative medicine market. In orthopedics, collagen fleece is used after open fractures, arthroplasty, amputations or spine surgery as prophylaxis. According to Climatric, a journal of the International Menopause Society report in 2021, Osteoporosis is the leading cause of over 8.9 million fractures yearly. Estimated that around 200 million women are affected with osteoporosis globally.
The rising number of people suffering from bone-related disorders and growing technological advancements or research/clinical trial studies drive the market’s growth. For Instance, in Sep 2021, PB Leiner announced the evidence based on a clinical study conducted to inspect joint pain in middle-aged physically active people who consume SOLUGEL collagen peptide. The study showed a significant reduction in discomfort and pain people were dealing with. This research was done by Florida State University and authorized by PB Leiner.

Source: DataM Intelligence Analysis (2021)
Global Collagen & Gelatin for Regenerative Medicine Market–Geographical Analysis
North America holds the largest market share of the global collagen & gelatin for regenerative medicine market.
North America dominates the global collagen & gelatin for regenerative medicine market, primarily attributed to the rising prevalence of bone or joint-related ailments such as osteoporosis, osteoarthritis and many more; established healthcare infrastructure and higher investment in R&D activities contribute to North America’s rapid share growth. Moreover, its broad base patient population also contributes to the growth of its share. According to the Osteoarthritis Action Alliance, in 2021, more than 32.5 million U.S. people have osteoarthritis, affecting around 25% of the world’s population.
Moreover, the growing number of product launches is responsible for the market’s growth. Other factors, such as the high spending of GDP on healthcare, stimulate the market’s growth. Many key developments, technological advancements, collaborations and agreements are taking place in this region. For instance, in Jan 2021, Integra Lifesciences Corporation announced that they completed the acquisition of ACell Inc. ACell is a company of innovative regenerative medicine with products and technology based on a porcine urinary bladder matrix platform.

Source: DataM Intelligence Analysis (2021)
Global Collagen & Gelatin for Regenerative Medicine Market- Competitive Landscape
The collagen & gelatin for regenerative medicine market is highly competitive with local and global companies’ presence. Integra Lifesciences Holdings Corporation, Nitta Gelatin, GELITA AG, Collagen Matrix Inc., Blafar Ltd., PB Leiner, Royal DSM, Symatese, Olaregen Therapeutics, Collagen Solutions Plc and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market’s growth. For instance, in May 2021, Olaregan Therapeutics, a Generex Biotechnology subsidiary, announced its distribution agreement with Nexgen Medical Sdn Bhd Inc. Nexgen will import and market wound care products, Excellagen, in Malaysia.

Integra Lifesciences Holdings Corporation:
Overview:
Integra LifeSciences Corp is a medical technology company that provides high-quality neurosurgical and regenerative tissue technology products, including Bactiseal, CerebroFlo, DuraSeal, Integra, MicroMatrix and many more.
Product Portfolio:
SurgiMend: It is a novel acellular collagen matrix extracted from the neonatal and fetal bovine dermis. It provides advantages for soft tissue reconstruction and repair over other biological or synthetic products.
Key Development: In Jul 2021, Integra LifeSciences Corporation, a company in medical technology, announced receiving a contract for innovative technology from Vizient Inc., a company of healthcare performance improvement for its soft tissue reconstruction product SurgiMend.

The global collagen & gelatin for regenerative medicine market report would provide access to approximately 40+ market data tables, 45+ figures, and 200 (approximate) pages.

상세 목차

1. Market Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. The rising novel product launches
4.1.1.2. Increasing research and development on these products
4.1.2. Restraints:
4.1.2.1. High cost related to collagen and gelatin regenerative medicines
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces
5.2. Unmet Needs
5.3. Supply chain Analysis
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. By Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
7.1.2. Market Attractiveness Index, By Type
7.2. Collagen *
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Gelatin
8. By Source
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
8.1.2. Market Attractiveness Index, By Source
8.2. Bovine*
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Porcine
8.4. Marine
8.5. Others
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Orthopedic *
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Wound care
9.4. Cardiovascular
9.5. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. The U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. The U.K.
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11. Competitive Landscape
11.1. Key Developments and Strategies
11.2. Company Share Analysis
11.3. Product Benchmarking
11.4. List of Key Companies to Watch
12. Company Profiles
12.1. Integra Lifesciences Holdings Corporation
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Key Highlights
12.1.4. Financial Overview
12.2. Nitta Gelatin
12.3. GELITA AG
12.4. Collagen Matrix Inc.
12.5. Blafar Ltd.
12.6. PB Leiner
12.7. Royal DSM
12.8. Symatese
12.9. Olaregen Therapeutics
12.10. Collagen Solutions Plc ( LIST NOT EXHAUSTIVE)
13. Global Collagen & Gelatin for Regenerative Medicine Market– DataM
13.1. Appendix
13.2. About Us and Services
13.3. Contact Us

언급된 주요 기업들

Integra Lifesciences Holdings Corporation, Nitta Gelatin, GELITA AG, Collagen Matrix Inc., Blafar Ltd., PB Leiner, Royal DSM, Symatese, Olaregen Therapeutics

표 목록 (Tables)

List of Tables

Table 1 Global Collagen & Gelatin for Regenerative Medicine Market Share, By Type, 2023, 2027 & 2031 (%)

Table 2 Global Collagen & Gelatin for Regenerative Medicine Market Value, By Source, 2023, 2027 & 2031 ($ Million)

Table 3 Global Collagen & Gelatin for Regenerative Medicine Market Value, By Application, 2023, 2027 & 2031 ($ Million)

Table 4 Global Collagen & Gelatin for Regenerative Medicine Market Value, By Region, 2023, 2027 & 2031 ($ Million)

Table 5 Global Collagen & Gelatin for Regenerative Medicine Market Value, By Type, 2023, 2027 & 2031 ($ Million)

Table 6 Global Collagen & Gelatin for Regenerative Medicine Market Value, By Type, 2022-2031 ($ Million)

Table 7 Global Collagen & Gelatin for Regenerative Medicine Market Value, By Source, 2023, 2027 & 2031 ($ Million)

Table 8 Global Collagen & Gelatin for Regenerative Medicine Market Value, By Source, 2022-2031 ($ Million)

Table 9 Global Collagen & Gelatin for Regenerative Medicine Market Value, By Application, 2023, 2027 & 2031 ($ Million)

Table 10 Global Collagen & Gelatin for Regenerative Medicine Market Value, By Application, 2022-2031 ($ Million)

Table 11 Global Collagen & Gelatin for Regenerative Medicine Market Value, By Region, 2023, 2027 & 2031 ($ Million)

Table 12 Global Collagen & Gelatin for Regenerative Medicine Market Value, By Region, 2022-2031 ($ Million)

Table 13 North America Collagen & Gelatin for Regenerative Medicine Market Value, By Type, 2022-2031 ($ Million)

Table 14 North America Collagen & Gelatin for Regenerative Medicine Market Value, By Source, 2022-2031 ($ Million)

Table 15 North America Collagen & Gelatin for Regenerative Medicine Market Value, By Application, 2022-2031 ($ Million)

Table 16 North America Collagen & Gelatin for Regenerative Medicine Market Value, By Country, 2022-2031 ($ Million)

Table 17 South America Collagen & Gelatin for Regenerative Medicine Market Value, By Type, 2022-2031 ($ Million)

Table 18 South America Collagen & Gelatin for Regenerative Medicine Market Value, By Source, 2022-2031 ($ Million)

Table 19 South America Collagen & Gelatin for Regenerative Medicine Market Value, By Application, 2022-2031 ($ Million)

Table 20 South America Collagen & Gelatin for Regenerative Medicine Market Value, By Country, 2022-2031 ($ Million)

Table 21 Europe Collagen & Gelatin for Regenerative Medicine Market Value, By Type, 2022-2031 ($ Million)

Table 22 Europe Collagen & Gelatin for Regenerative Medicine Market Value, By Source, 2022-2031 ($ Million)

Table 23 Europe Collagen & Gelatin for Regenerative Medicine Market Value, By Application, 2022-2031 ($ Million)

Table 24 Europe Collagen & Gelatin for Regenerative Medicine Market Value, By Country, 2022-2031 ($ Million)

Table 25 Asia-Pacific Collagen & Gelatin for Regenerative Medicine Market Value, By Type, 2022-2031 ($ Million)

Table 26 Asia-Pacific Collagen & Gelatin for Regenerative Medicine Market Value, By Source, 2022-2031 ($ Million)

Table 27 Asia-Pacific Collagen & Gelatin for Regenerative Medicine Market Value, By Application, 2022-2031 ($ Million)

Table 28 Asia-Pacific Collagen & Gelatin for Regenerative Medicine Market Value, By Country, 2022-2031 ($ Million)

Table 29 Middle East & Africa Collagen & Gelatin for Regenerative Medicine Market Value, By Type, 2022-2031 ($ Million)

Table 30 Middle East & Africa Collagen & Gelatin for Regenerative Medicine Market Value, By Source, 2022-2031 ($ Million)

Table 31 Middle East & Africa Collagen & Gelatin for Regenerative Medicine Market Value, By Application, 2022-2031 ($ Million)

Table 32 Integra Lifesciences Holdings Corporation: Overview

Table 33 Integra Lifesciences Holdings Corporation: Product Portfolio

Table 34 Integra Lifesciences Holdings Corporation: Key Developments

Table 35 Nitta Gelatin: Overview

Table 36 Nitta Gelatin: Product Portfolio

Table 37 Nitta Gelatin: Key Developments

Table 38 GELITA AG: Overview

Table 39 GELITA AG: Product Portfolio

Table 40 GELITA AG: Key Developments

Table 41 Collagen Matrix Inc.: Overview

Table 42 Collagen Matrix Inc.: Product Portfolio

Table 43 Collagen Matrix Inc.: Key Developments

Table 44 Blafar Ltd.: Overview

Table 45 Blafar Ltd.: Product Portfolio

Table 46 Blafar Ltd.: Key Developments

Table 47 PB Leiner: Overview

Table 48 PB Leiner: Product Portfolio

Table 49 PB Leiner: Key Developments

Table 50 Royal DSM: Overview

Table 51 Royal DSM: Product Portfolio

Table 52 Royal DSM: Key Developments

Table 53 Symatese: Overview

Table 54 Symatese: Product Portfolio

Table 55 Symatese: Key Developments

Table 56 Olaregen Therapeutics: Overview

Table 57 Olaregen Therapeutics: Product Portfolio

Table 58 Olaregen Therapeutics: Key Developments

Table 59 Collagen Solutions Plc: Overview

Table 60 Collagen Solutions Plc: Product Portfolio

Table 61 Collagen Solutions Plc: Key Development

그림 목록 (Figures)

List of Figures

Figure 1 Global Collagen & Gelatin for Regenerative Medicine Market Share, By Type, 2023 & 2031 (%)

Figure 2 Global Collagen & Gelatin for Regenerative Medicine Market Share, By Source, 2023 & 2031 (%)

Figure 3 Global Collagen & Gelatin for Regenerative Medicine Market Share, By Application, 2023 & 2031 (%)

Figure 4 Global Collagen & Gelatin for Regenerative Medicine Market Share, By Region, 2023 & 2031 (%)

Figure 5 Global Collagen & Gelatin for Regenerative Medicine Market Value, 2022-2031 ($ Million)

Figure 6 Global Collagen & Gelatin for Regenerative Medicine Market Y-o-Y Growth, By Type, 2021-2029 (%)

Figure 7 Collagen: Global Collagen & Gelatin for Regenerative Medicine Market Value, 2022-2031 ($ Million)

Figure 8 Gelatin: Global Collagen & Gelatin for Regenerative Medicine Market Value, 2022-2031 ($ Million)

Figure 9 Global Collagen & Gelatin for Regenerative Medicine Market Y-o-Y Growth, By Source, 2021-2029 (%)

Figure 10 Bovine: Global Collagen & Gelatin for Regenerative Medicine Market Value, 2022-2031 ($ Million)

Figure 11 Porcine: Global Collagen & Gelatin for Regenerative Medicine Market Value, 2022-2031 ($ Million)

Figure 12 Marine: Global Collagen & Gelatin for Regenerative Medicine Market Value, 2022-2031 ($ Million)

Figure 13 Others: Global Collagen & Gelatin for Regenerative Medicine Market Value, 2022-2031 ($ Million)

Figure 14 Global Collagen & Gelatin for Regenerative Medicine Market Y-o-Y Growth, By Application, 2021-2029 (%)

Figure 15 Orthopedic: Global Collagen & Gelatin for Regenerative Medicine Market Value, 2022-2031 ($ Million)

Figure 16 Wound Care: Global Collagen & Gelatin for Regenerative Medicine Market Value, 2022-2031 ($ Million)

Figure 17 Cardiovascular: Global Collagen & Gelatin for Regenerative Medicine Market Value, 2022-2031 ($ Million)

Figure 18 Others: Global Collagen & Gelatin for Regenerative Medicine Market Value, 2022-2031 ($ Million)

Figure 19 Global Collagen & Gelatin for Regenerative Medicine Market Y-o-Y Growth, By Region, 2021-2029 (%)

Figure 20 North America Collagen & Gelatin for Regenerative Medicine Market Value, 2022-2031 ($ Million)

Figure 21 North America Collagen & Gelatin for Regenerative Medicine Market Share, By Type, 2023 & 2031 (%)

Figure 22 North America Collagen & Gelatin for Regenerative Medicine Market Share, By Source, 2023 & 2031 (%)

Figure 23 North America Collagen & Gelatin for Regenerative Medicine Market Share, By Application, 2023 & 2031 (%)

Figure 24 North America Collagen & Gelatin for Regenerative Medicine Market Share, By Country, 2023 & 2031 (%)

Figure 25 South America Collagen & Gelatin for Regenerative Medicine Market Value, 2022-2031 ($ Million)

Figure 26 South America Collagen & Gelatin for Regenerative Medicine Market Share, By Type, 2023 & 2031 (%)

Figure 27 South America Collagen & Gelatin for Regenerative Medicine Market Share, By Source, 2023 & 2031 (%)

Figure 28 South America Collagen & Gelatin for Regenerative Medicine Market Share, By Application, 2023 & 2031 (%)

Figure 29 South America Collagen & Gelatin for Regenerative Medicine Market Share, By Country, 2023 & 2031 (%)

Figure 30 Europe Collagen & Gelatin for Regenerative Medicine Market Value, 2022-2031 ($ Million)

Figure 31 Europe Collagen & Gelatin for Regenerative Medicine Market Share, By Type, 2023 & 2031 (%)

Figure 32 Europe Collagen & Gelatin for Regenerative Medicine Market Share, By Source, 2023 & 2031 (%)

Figure 33 Europe Collagen & Gelatin for Regenerative Medicine Market Share, By Application, 2023 & 2031 (%)

Figure 34 Europe Collagen & Gelatin for Regenerative Medicine Market Share, By Country, 2023 & 2031 (%)

Figure 35 Asia-Pacific Collagen & Gelatin for Regenerative Medicine Market Value, 2022-2031 ($ Million)

Figure 36 Asia-Pacific Collagen & Gelatin for Regenerative Medicine Market Share, By Type, 2023 & 2031 (%)

Figure 37 Asia-Pacific Collagen & Gelatin for Regenerative Medicine Market Share, By Source, 2023 & 2031 (%)

Figure 38 Asia-Pacific Collagen & Gelatin for Regenerative Medicine Market Share, By Application, 2023 & 2031 (%)

Figure 39 Asia-Pacific Collagen & Gelatin for Regenerative Medicine Market Share, By Country, 2023 & 2031 (%)

Figure 40 Middle East & Africa Collagen & Gelatin for Regenerative Medicine Market Value, 2022-2031 ($ Million)

Figure 41 Middle East & Africa Collagen & Gelatin for Regenerative Medicine Market Share, By Type, 2023 & 2031 (%)

Figure 42 Middle East & Africa Collagen & Gelatin for Regenerative Medicine Market Share, By Source, 2023 & 2031 (%)

Figure 43 Middle East & Africa Collagen & Gelatin for Regenerative Medicine Market Share, By Application, 2023 & 2031 (%)

Figure 44 Integra Lifesciences Holdings Corporation: Financials

Figure 45 Nitta Gelatin: Financials

Figure 46 GELITA AG: Financials

Figure 47 Collagen Matrix Inc.: Financials

Figure 48 Blafar Ltd.: Financials

Figure 49 PB Leiner: Financials

Figure 50 Royal DSM: Financials

Figure 51 Symatese: Financials

Figure 52 Olaregen Therapeutics: Financials

Figure 53 Collagen Solutions Plc: Financials